Alternatively spliced tissue factor - One cut too many?

Thrombosis and Haemostasis

Volumn 97, Issue 1, 2007, Pages 5-8

  Mackman, Nigel ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 7A; CELL SURFACE RECEPTOR; EPITOPE; MESSENGER RNA; PROCOAGULANT; RECOMBINANT DNA; RECOMBINANT THROMBOPLASTIN; THROMBOPLASTIN; THROMBOPLASTIN[1-219]; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; BINDING SITE; BLOOD CLOTTING; CRYSTAL STRUCTURE; DISULFIDE BOND; DRUG STRUCTURE; EDITORIAL; EXON; GENE OVEREXPRESSION; HUMAN; INTRON; MUTAGENESIS; PREDICTION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN STRUCTURE; SITE DIRECTED MUTAGENESIS; STRUCTURE ACTIVITY RELATION;

ALTERNATIVE SPLICING; EXONS; FACTOR VIIA; FACTOR X; HUMANS; MULTIPROTEIN COMPLEXES; PROTEIN BINDING; RNA, MESSENGER; THROMBOPLASTIN;

EID: 33846944344     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH06-11-0670     Document Type: Editorial

References (37)

1. Mackman N. Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterioscler Thromb Vasc Biol 2004; 24: 1015-22.
2. Mackman N, Morrissey JH, Fowler B, et al. Complete sequence of the human tissue factor gene, a highly regulated cellular receptor that initiates the coagulation protease cascade. Biochemistry 1989; 28: 1755-62.
3. Ruf W, Schullek JR, Stone MJ, et al. Mutational mapping of functional residues in tissue factor: identification of factor VII recognition determinants in both structural modules of the predicted cytokine receptor homology domain. Biochemistry 1994; 33: 1565-72.
4. Muller YA, Ultsch MH, Kelley RF, et al. Structure of the extracellular domain of human tissue factor: Location of the factor VIIa binding site. Biochemistry 1994; 33: 10864-70.
5. Banner DW, D'Arcy A, Chene C, et al. The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor. Nature 1996; 380: 41-6.
6. Ruf W, Miles DJ, Rehemtulla A, et al. Cofactor residues lysine 165 and 166 are critical for protein substrate recognition by the tissue factor-factor VIIa protease complex. J Biol Chem 1992; 267: 6375-81.
7. Roy S, Hass PE, Bernell JH, et al. Lysine residues 165 and 166 are essential for the cofactor function of tissue factor. J Biol Chem 1991; 266: 22063-6.
8. Huang Q, Neuenschwander PF, Rezaie AR, et al. Substrate recognition by tissue factor-factor VIIa. Evidence for interaction of residues Lys165 and Lys166 of tissue factor with the 4-carboxyglutamate-rich domain of factor X. J Biol Chem 1996; 271: 21752-7.
9. Huang M, Syed R, Stura EA, et al. The mechanism of an inhibitory antibody on TF-initiated blood coagulation revealed by the crystal structures of human tissue factor, Fab 5G9 and TF.G9 complex. J Mol Biol 1998; 275: 873-94.
10. Kirchhofer D, Moran P, Chiang N, et al. Epitope location on tissue factor determines the anticoagulant potency of monoclonal anti-tissue factor antibodies. Thromb Haemost 2000; 84: 1072-81.
11. Ohto U, Mizutani R, Nakamura M, et al. Crystal structure of a humanized Fab fragment of anti-tissue-factor antibody in complex with tissue factor. J Synchrotron Radiat 2004; 11: 105-8.
12. Chen VM, Ahamed J, Versteeg HH, et al. Evidence for activation of tissue factor by an allosteric disulfide bond. Biochemistry 2006; 45: 12020-8.
13. Norledge BV, Petrovan RJ, Ruf W, et al. The tissue factor/factor VIIa/ factor Xa complex: a model built by docking and site-directed mutagenesis. Proteins 2003; 53: 640-8.
14. Chen SW, Pellequer JL, Schved JF, et al. Model of a ternary complex between activated factor VII, tissue factor and factor IX. Thromb Haemost 2002; 88: 74-82.
15. Ruf W, Rehemtulla A, Edgington TS. Phospholipid-independent and -dependent interactions required for tissue factor receptor and cofactor function. J Biol Chem 1991; 266: 2158-66.
16. Neuenschwander PF, Morrissey JH. Deletion of the membrane anchoring region of tissue factor abolishes autoactivation of factor VII but not cofactor function. J Biol Chem 1992; 267: 14477-82.
17. Paborsky LR, Caras IW, Fisher KL, et al. Lipid association, but not the transmembrane domain, is required for tissue factor activity. Substitution of the transmembrane domain with a phosphatidylinositol anchor. J Biol Chem 1991; 266: 21911-6.
18. Morrissey JH, Neuenschwander PF, Huang Q, et al. Factor VIIa-tissue factor: functional importance of protein-membrane interactions. Thromb Haemost 1997; 78: 112-6.
19. Waxman E, Ross JBA, Laue TM, et al. Tissue factor and its extracellular soluble domain: The relationship between intermolecular association with factor VIIa and enzymatic activity of the complex. Biochemistry 1992; 31: 3998-4003.
20. Fiore MM, Neuenschwander PF, Morrissey JH. The biochemical basis for the apparent defect of soluble mutant tissue factor in enhancing the proteolytic activities of factor VIIa. J Biol Chem 1994; 269: 143-9.
21. Garcia-Blanco MA. Messenger RNA reprogramming by spliceosome-mediated RNA trans-splicing. J Clin Invest 2003; 112: 474-80.
22. Crossman DC, Carr DP, Tuddenham EGD, et al. The regulation of tissue factor mRNA in human endothelial cells in response to endotoxin or phorbol ester. J Biol Chem 1990; 265: 9782-7.
23. Brand K, Fowler BJ, Edgington TS, et al. Tissue factor mRNA in THP-1 monocytic cells is regulated at both transcriptional and posttranscriptional levels in response to lipopolysaccharide. Mol Cell Biel 1991; 11: 4732-8.
24. van der Logt CPE, Reitsma PH, Bertina RM. Alternative splicing is responsible for the presence of two tissue factor mRNA species in LPS stimulated human monocytes. Thromb Haemost 1992; 67: 272-6.
25. Chand HS, Ness SA, Kisiel W. Identification of a novel human tissue factor splice variant that is upregulated in tumor cells. Int J Cancer 2006; 118: 1713-20.
26. Bogdanov VY, Balasubramanian V, Hathcock J, et al. Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein. Nat Med 2003; 9: 458-62.
27. Guo W, Wang H, Zhao W, et al. Effect of all-trans retinoic acid and arsenic trioxide on tissue factor expression in acute promyelocytic leukemia cells. Chin Med J (Engl) 2001; 114: 30-4.
28. Szotowski B, Antomak S, Poller W, et al. Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines. Circ Res 2005; 96: 1233-9.
29. Szotowski B, Goldin-Lang P, Antoniak S, et al. Alterations in myocardial tissue factor expression and cellular localization in dilated cardiomyopathy. J Am Coll Cardiol 2005; 45: 1081-9.
30. Yu JL, May L, Lhotak V, et al. Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis. Blood 2005; 105: 1734-41.
31. Bogdanov VY, Kirk RI, Miller C, et al. Identification and characterization of murine alternatively spliced tissue factor. J Thromb Haemost 2006; 4: 158-67.
32. Bruggemann LW, Drijfhout JW, Reitsma PH, et al. Alternatively spliced tissue factor in mice: induction by Streptococcus pneumoniae. J Thromb Haemost 2006; 4: 918-20.
33. Young JL, Libby P, Schönbeck U. Cytokines in the pathogenesis of atherosclerosis. Thromb Haemost 2002; 88: 554-67.
34. Censarek P, Bobbe A, Schror K, et al. Alternatively spliced human tissue factor (asHTF) is not procoagulant. Thromb Haemost 2007; 97: 11-14.
35. Hedner U. NovoSeven as a universal haemostatic agent. Blood Coagul Fibrinolysis 2000; 11 (Suppl 1): S107-S111.
36. Butenas S, Bouchard BA, Brummel-Ziedins KE, et al. Tissue factor activity in whole blood. Blood 2005; 105: 2764-70.
37. Kelley RF, Refino CJ, O'Connell MP, et al. A soluble tissue factor mutant is a selective anticoagulant and antithrombotic agent. Blood 1997; 89: 3219-27.